Min Jun's Publications

About Min Jun's Publications

Program Lead

  • Prevalence of chronic kidney disease in Asia: a systematic review and analysis

    BMJ Global Health Date published:

  • The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis

    Pharmacoepidemiology and Drug Safety Date published:

  • A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)

    Journal of Viral Hepatitis Date published:

  • The Comparative Effectiveness and Safety of Direct Oral Anticoagulant (DOAC) and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category

    Journal of the American Society of Nephrology Date published:

  • The Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category

    Journal of the American Society of Nephrology Date published:

  • The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation

    Clinical Journal of the American Society of Nephrology Date published:

  • Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis

    Kidney International Reports Date published:

  • PLASMA FATTY ACIDS AND THE RISK OF VASCULAR AND MORTALITY OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE STUDY

    Journal of Hypertension Date published:

  • The Potential Effectiveness of COVID-Related Smoking Cessation Messages in Three Countries

    Nicotine and Tobacco Research Date published:

  • Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

    Kidney International Reports Date published:

  • PLASMA FATTY ACIDS AND THE RISK OF VASCULAR AND MORTALITY OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE STUDY

    Date published:

  • CLINICAL OUTCOMES AND PATIENT CHARACTERISTICS ACCORDING TO THE COMBINATION OF TEN-YEAR RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND SYSTOLIC BLOOD PRESSURE

    Date published:

  • Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis

    Date published:

  • The Impact of Clinical Presentation on Survival in Patients Requiring Hemodialysis Catheters for Acute and Unplanned Dialysis: A Prospective Observational Study

    Canadian Journal of Kidney Health and Disease Date published:

  • Workforce capacity for the care of patients with kidney failure across world countries and regions

    BMJ Global Health Date published: